Capital Investment Advisors, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Investment Advisors, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$364,904
+15.7%
40,5900.0%0.01%0.0%
Q3 2023$315,384
-19.7%
40,5900.0%0.01%
-25.0%
Q2 2023$392,911
-11.2%
40,590
+0.6%
0.01%
-7.7%
Q1 2023$442,400
+254152.9%
40,3650.0%0.01%
+160.0%
Q4 2022$174
-99.9%
40,365
+32.9%
0.01%
-37.5%
Q3 2022$228,000
-23.2%
30,365
+2.7%
0.01%
-20.0%
Q2 2022$297,000
-16.8%
29,565
+2.5%
0.01%
-9.1%
Q1 2022$357,000
+4.1%
28,840
+92.3%
0.01%
+10.0%
Q4 2021$343,000
+19.1%
15,000
+15.4%
0.01%0.0%
Q3 2021$288,000
+121.5%
13,000
+30.0%
0.01%
+150.0%
Q2 2021$130,00010,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders